Navigation Links
Michael J. Fox Foundation awards Mayo Clinic researcher grant to advance Parkinson’s research
Date:3/2/2010

JACKSONVILLE, Fla. For his work contributing to a potential new treatment approach for Parkinson's disease, the Michael J. Fox Foundation (MJFF) for Parkinson's Research has awarded a $500,000 grant to a neuroscientist at the Mayo Clinic campus in Florida.

The researcher, Matthew Farrer, Ph.D., studies how a gene, known as LRRK2, functions normally within brain nerve cells (neurons), and also how it can go awry when mutated. Dr. Farrer was part of the original team who discovered the link between LRRK2 and Parkinson's disease in 2004. A year later, he described LRRK2 G2019S, believed now to be the most common genetic risk factor for Parkinson's disease.

For these reasons, MJFF has identified LRRK2 as a high-priority therapeutic target and has invested nearly $17 million to date for a broad and integrated strategy to drive critical LRRK2-related initiatives at every stage of drug development, according to the foundation. As part of those awards, on Feb. 17, MJFF announced grants of $3.5 million to nine research studies.

Dr. Farrer's work in teasing apart the function of LRRK2 in dictating the structure of neurons earned him the two-year grant. The co-principal investigator on the grant is Justus Daechsel, Ph.D., an assistant professor of Molecular Neuroscience at Mayo Clinic.

"At Mayo, our molecular neuroscience research is now focused on the genetic basis of Parkinson's disease, on the specific proteins and the molecular pathways that are affected," Dr. Farrer says. "Our model and drug development program is designed to halt disease progression, not just to treat the symptoms."

Dr. Farrer and his team have genetically altered mice so that they do not have the LRRK2 gene. When brain cells from these animals are grown in laboratory culture, the researchers have found that neurons without LRKK2 branch out more than do neurons with LRRK2, which shows that the gene normally helps regulate neuronal architecture.

They are using the mice to further understand the function of the protein produced by the LRKK2 gene. "It is a large protein, with many parts. So we are going to replace pieces of the protein, with and without the mutations that predispose people to develop Parkinson's disease, back into cells derived from these animals to see what roles different regions of the protein play," he says. They will also delete other proteins known to interact with the LRRK2 protein to see their effect.

"Answers to these questions are critical for future drug development for patients with Parkinson's disease, and we are pleased the support of the Michael J. Fox Foundation can help us reach our common goal," Dr. Farrer says.


'/>"/>

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. Would You Like to Own a Thriller Album Autographed by Michael Jackson Himself?
4. Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division
5. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
6. Aleres Dr. Michael Taitel Presents Compelling Evidence at IBI/NBCH Health & Productivity Forum that Wellness Programs Positively Impact Health & Productivity
7. Michael Jackson Propofol Expert, Barry Friedberg MD, Spoke at Pan Pacific Surgery Meeting
8. TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives
9. Michael J. Fox Foundation Awards $2 Million for Clinical Research on Postural Instability and Gait Disturbances in Parkinsons Disease
10. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
11. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... As health professionals work to improve their approach to ... is doing more than filling out a survey; in many cases health professionals and ... in health care and research on the importance of active engagement with patients and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology: